Recs

2
Player Avatar vrkap (83.19) Submitted: 4/3/2007 1:28:25 PM : Outperform Start Price: $21.45 NDSN Score: +232.01

I came across this recently and am very positive on this stock. I think recent sell offs make for an attractive entry point.

On a EV/EBITDA basis these guys are trading below their 5 yr and 10yr average ranges. In addition, their latest acquisition helps them move into the higher growth/more volatile High Technology industry which while still tempered by their traditional businesses earns the co an overall higher multiple.

I believe the noise related to the inventory step up charges etc has been overblow and if the non-recuriings are backed out this stock begins to look cheaper. the deal is overall accretive and markets seem to be overreacting to the .12-.14 cents of step-up charges which were above their initial estimates. On a cash eps basis - the deal is already accretive.

I like their mix and i think risk is somewhat hedged across the portfolio - its still an economy dependent stock but these guys are primed to benefit from larger trends (buying of plasmas etc) but since they are a few steps down the food chain they havent received that premium valuation. I'm buying this stock farily agressively at these levels and have at PT of $60.

Featured Broker Partners


Advertisement